NIH Repurposing Generic (ReGen) Drugs Evidence Package Challenge

NIH has launched a prize competition to expand access to affordable treatments for conditions that place a high burden on the healthcare ecosystem. As part of NIH’s Bio Genesis Mission, the National Center for Advancing Translational Sciences is administering this challenge to kick-start a multi-step program.

The $4 million Repurposing Generic (ReGen) Drugs Evidence Package Challenge will award up to 40 prizes of $100,000 each for promising generic drug candidates that could be repurposed to treat conditions that cost the healthcare system more than $1 billion annually. Chronic kidney disease and diabetes are included in the list of costly conditions. Individuals, teams, and organizations from any sector may enter.

Key Dates

Intent-to-apply registration deadline: January 15, 2027 at 5:00 PM ET.

Evidence package submission deadline: March 26, 2027